MUC (Ursodeoxycholic Acid and Chenodeoxycholic Acid Tryhydrate Magnesium Salt)

At ICE Pharma, we are a leading global manufacturer and supplier of Ursodeoxycholic Acid and Chenodeoxycholic Acid Trihydrate Magnesium salt, a combination bile acid salt renowned for its efficacy in dissolving cholesterol gallstones and providing hepatoprotective effects. Using our existing bovine derived bile acid API’s, ICE Pharma manufactures this trihydrated salt of CDCA and UDCA in a crystalline form. Our product is synthesized under stringent Good Manufacturing Practice (GMP) conditions, ensuring exceptional purity and consistency for pharmaceutical applications.

Product Description

Ursodeoxycholic Acid and Chenodeoxycholic Acid Trihydrate Magnesium salt is a synthetic bile acid salt combining the therapeutic properties of ursodeoxycholic acid (UDCA) and chenodeoxycholic acid (CDCA) in a magnesium trihydrate form. This enhances the solubility and bioavailability of bile acids, facilitating effective dissolution of cholesterol-rich gallstones and offering protective benefits to liver tissues.

Applications

This API is utilised in the formulation of pharmaceutical products aimed at treating various hepatobiliary disorders, including:

• Cholesterol Gallstones: Effective in dissolving radiolucent cholesterol gallstones in patients with functioning gallbladders, providing a non-surgical treatment option.
• Hepatoprotective Agent: Offers protective effects against liver fibrosis and oxidative stress-induced liver damage.

End Uses

MUC (Ursodeoxycholic Acid and Chenodeoxycholic Acid Trihydrate Magnesium Salt) is used as an active pharmaceutical ingredient in certain formulations for the treatment of biliary indigestion and gallstone dissolution. Its combined bile acid profile enhances therapeutic efficacy in managing hepatobiliary conditions where improved bile flow and cholesterol solubilization are critical.